Scailyte AG

Scailyte develops artificial intelligence technology for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into diseases by uncovering human's hidden "single-cell"​ secrets. Our AI-based software ScaiVision, offers best-in-class performance for supervised pattern recognition analysis of single-cell data. The performance and clinically-relevant application of the deep learning algorithm has been demonstrated in a scientific publication by our co-founder Prof. Claassen (ETH Zurich). ScaiVision will allow our customers to reduce data analysis time and costs, while increasing groundbreaking insights

Scailyte AG Switzerland
25/11/2020
Full time
Company description: Scailyte is a globally recognized, leading startup, spin-off from ETH Zürich. We focus on AI-driven single‐cell analysis to make groundbreaking discoveries as well as reveal disease‐specific biomarkers, enabling new avenues in precision medicine and personalized therapy. Our approach comprises three key pillars: High-quality biomedical data sets in disease areas with unmet need for early and accurate diagnostics, generated through excellent project design and execution in partnership with top clinical researchers. Targeted and sensitive algorithms to extract clinically relevant insight, integrated into a proprietary data analytics platform through continuous development and application of most appropriate technology. Industrialization and adoption of our ultra-sensitive biomarkers, through an established and growing network of top clinicians and industry leaders in diagnostics and pharma. Position description: We are looking for a self-driven and...